15163 - ISTH "Antiphospholipid Antibody Syndrome"
Join Maria Laura Bertolaccini and Bas de Laat for this webinar to learn about the diagnosis and management of antiphospholipid antibody syndrome. The diagnosis of the antiphospholipid syndrome is made on the basis of occurrence of thrombosis and the detection of antiphospholipid antibodies. As thrombosis has a high prevalence in the human population, the detection of antiphospholipid antibodies has to be accurate and precise. During this webinar, de Laat will discuss the detection of antiphospholipid antibodies in detail highlighting problems that one might face. Bertolaccini will discuss the treatment options after diagnosis.
Part I: Detection
Bas de Laat, Maastricht University Medical Center (the Netherlands)
Part II: State of the Art Treatment
Maria Laura Bertolaccini, Kings College London (UK)
Moderator:
Gevorg Tamamyam, MD Anderson Cancer Center (USA) and Yerevan State Medical University (Armenia)
Accreditation Statement
Target Audience
- Clinical scientists
- Clinical chemists
- Scientists in the field of thrombosis
- MD internal medicine
- MD rheumatology
Learning Objectives
At the conclusion of this activity, I will be able to:
- Identify the laboratory criteria for the antiphospholipid syndrome
- Apply the laboratory criteria for the antiphospholipid syndrome
- Explain the pitfalls within the current laboratory criteria for the antiphospholipid syndrome
- How can the current laboratory assays be improved; long term versus short term
Name | Company | Role |
Chris Ward, MD | Bayer | Advisory Board, Speaker |
| Pfizer, BMS | Advisory Board, Speaker |
| Boehringer-Ingelheim | Advisory Board, Speaker |
| Alexion | Advisory Board |
| Medimark | Steering Committee Member, Speaker |
Geoff Barnes | BMS, Pfizer, Blue Cross Blue Shield of Michigan | Primary Investigator & Co-Investigator |
Yukio Ozaki | Sysmex | Advisory Board |
Bas de Laat | Diagnostica Stago | Consultant |
Siemens | Speaker | |
Phadia | Speaker |
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
Price
Required Hardware/software
To view the webcast on your computer go to https://www.isth.org/ click the Events/Webinars tab and view the ISTH 2015 Archived Webinars